News and Trends 1 Feb 2022
Ribbon Biolabs Pushes DNA Synthesis Length Limits with €18M Series A
The Viennese biotech startup Ribbon Biolabs has raised an €18M Series A round to reduce the costs of synthesizing long DNA molecules, which could accelerate research into synthetic biology and the storage of data as DNA. Supported by lead investor Hadean Ventures, Ribbon Biolabs’ fundraising round is part and parcel of a continuing investor interest […]